IXJ:NYE-iShares Global Healthcare ETF (USD)

ETF | Health |

Last Closing

USD 97.58

Change

-0.58 (-0.59)%

Market Cap

N/A

Volume

0.14M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-01 )

Largest Industry Peers for Health

Symbol Name Price(Change) Market Cap
XLV Health Care Select Sector SPDR..

-0.81 (-0.53%)

USD 41.71B
FHLC Fidelity® MSCI Health Care In..

-0.46 (-0.63%)

USD 2.97B
FXH First Trust Health Care AlphaD..

-1.05 (-0.94%)

USD 1.29B
PPH VanEck Pharmaceutical ETF

-0.49 (-0.52%)

USD 0.72B
XHE SPDR® S&P Health Care Equipme..

-2.02 (-2.23%)

USD 0.22B
IDNA iShares Genomics Immunology an..

-0.15 (-0.63%)

USD 0.14B
SBIO ALPS Medical Breakthroughs ETF

+0.19 (+0.51%)

USD 0.11B
XHS SPDR® S&P Health Care Service..

-1.90 (-1.96%)

USD 0.08B
HTEC Robo Global® Healthcare Techn..

-0.39 (-1.32%)

USD 0.06B
BBP Virtus LifeSci Biotech Product..

-0.71 (-1.13%)

USD 0.02B

ETFs Containing IXJ

IXJ:AU iShares Global Healthcare.. 99.88 % 0.00 %

+0.10 (+0.07%)

USD 1.46B
XHC:CA iShares Global Healthcare.. 0.00 % 0.65 %

-0.17 (0.07%)

CAD 0.65B

Market Performance

  Market Performance vs. Industry/Classification (Health) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 12.52% 73% C 64% D
Dividend Return 0.78% 59% D- 12% F
Total Return 13.30% 73% C 59% D-
Trailing 12 Months  
Capital Gain 20.19% 36% F 53% F
Dividend Return 1.51% 79% B- 19% F
Total Return 21.70% 36% F 48% F
Trailing 5 Years  
Capital Gain 63.04% 68% D+ 74% C
Dividend Return 6.41% 68% D+ 18% F
Total Return 69.45% 68% D+ 72% C
Average Annual (5 Year Horizon)  
Capital Gain 7.46% N/A N/A 62% D
Dividend Return 8.42% N/A N/A 57% F
Total Return 0.96% N/A N/A 22% F
Risk Return Profile  
Volatility (Standard Deviation) 10.70% N/A N/A 76% C+
Risk Adjusted Return 78.71% N/A N/A 89% A-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike